• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾结石与常染色体显性遗传性多囊肾病的关联。

The association of nephrolithiasis and autosomal dominant polycystic kidney disease.

作者信息

Torres V E, Erickson S B, Smith L H, Wilson D M, Hattery R R, Segura J W

机构信息

Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905.

出版信息

Am J Kidney Dis. 1988 Apr;11(4):318-25. doi: 10.1016/s0272-6386(88)80137-9.

DOI:10.1016/s0272-6386(88)80137-9
PMID:3354568
Abstract

Despite the frequency and morbidity of nephrolithiasis in autosomal dominant polycystic kidney disease (ADPKD), this association has not been subject to a detailed study. One hundred fifty-one of 751 ADPKD patients seen at the Mayo Clinic between 1976 and 1986 had nephrolithiasis. Seventy-four had passed calculi or had stones surgically removed. Stone analysis was available in 30 patients: uric acid, calcium oxalate, calcium phosphate, and struvite were present in 56.6%, 46.6%, 20%, and 10%, respectively. Calculi were observed in 71 of 79 patients with excretory urograms available for review. Faintly opaque and bull's eye stones, probably containing uric acid, were present in 12.7% and 14.1% of these patients, respectively. Precaliceal tubular ectasia was observed in 15.5%. Ninety-seven patients had preserved renal function (serum creatinine less than 1.5 mg/dL) at the initial evaluation. Six were excluded because they had other known causes of stone disease. The most common metabolic abnormality in the remaining 91 patients was hypocitric aciduria (ten of 15 patients with measurements). The urine pH in the first voided morning specimens (5.66 +/- 0.05) was significantly lower than that of an unselected control population (5.92 +/- 0.03, P less than 0.001). Hyperuricosuria, hyperoxaluria, and hypercalciuria were observed in six of 32 (18.8%), six of 31 (19.4%), and three of 39 (9.7%) patients with preserved renal function. The composition of the stones, the frequency of hypocitric aciduria, and the low urine pH (possibly related to the defect in excretion of ammonia described in ADPKD), suggest that metabolic, along with mechanical, factors are responsible for the frequent occurrence of nephrolithiasis in this disease.

摘要

尽管常染色体显性多囊肾病(ADPKD)中肾结石的发病率较高且具有临床意义,但这种关联尚未得到详细研究。1976年至1986年间在梅奥诊所就诊的751例ADPKD患者中,有151例患有肾结石。74例患者的结石已排出或通过手术取出。30例患者进行了结石分析:尿酸、草酸钙、磷酸钙和鸟粪石分别占56.6%、46.6%、20%和10%。在79例有排泄性尿路造影可供复查的患者中,有71例观察到结石。这些患者中分别有12.7%和14.1%存在可能含有尿酸的轻度不透光结石和靶心样结石。观察到15.5%的患者有肾盏前肾小管扩张。97例患者在初次评估时肾功能正常(血清肌酐低于1.5mg/dL)。6例因有其他已知的结石病病因被排除。其余91例患者中最常见的代谢异常是低枸橼酸尿症(15例有检测结果的患者中有10例)。晨尿首次排尿标本的尿液pH值(5.66±0.05)显著低于未选择的对照人群(5.92±0.03,P<0.001)。在32例肾功能正常的患者中,有6例(18.8%)出现高尿酸尿症,31例中有6例(19.4%)出现高草酸尿症,39例中有3例(9.7%)出现高钙尿症。结石的成分、低枸橼酸尿症的发生率以及低尿液pH值(可能与ADPKD中描述的氨排泄缺陷有关)表明,代谢因素以及机械因素共同导致了该疾病中肾结石的频繁发生。

相似文献

1
The association of nephrolithiasis and autosomal dominant polycystic kidney disease.肾结石与常染色体显性遗传性多囊肾病的关联。
Am J Kidney Dis. 1988 Apr;11(4):318-25. doi: 10.1016/s0272-6386(88)80137-9.
2
Renal stone disease in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的肾结石病
Am J Kidney Dis. 1993 Oct;22(4):513-9. doi: 10.1016/s0272-6386(12)80922-x.
3
Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients.常染色体显性多囊肾病中的钙化性肾结石和囊肿钙化:84例患者的临床及CT研究
AJR Am J Roentgenol. 1992 Jul;159(1):77-81. doi: 10.2214/ajr.159.1.1609726.
4
Metabolic abnormalities associated with calyceal diverticular stones.与肾盏憩室结石相关的代谢异常。
BJU Int. 2006 May;97(5):1053-6. doi: 10.1111/j.1464-410X.2006.06134.x.
5
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
6
[Functional evaluation in patients with kidney calculi].[肾结石患者的功能评估]
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8.
7
Multiple sclerosis and nephrolithiasis: a matched-case comparative study.多发性硬化症与肾结石:一项配对病例对照研究。
BJU Int. 2017 Jun;119(6):919-925. doi: 10.1111/bju.13820. Epub 2017 Mar 17.
8
Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.常染色体显性多囊肾病患者肾结石的评估
Clin J Am Soc Nephrol. 2009 Apr;4(4):838-44. doi: 10.2215/CJN.03100608. Epub 2009 Apr 1.
9
Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?感染性肾结石患者的代谢评估:有必要吗?
Arch Ital Urol Androl. 2016 Oct 5;88(3):208-211. doi: 10.4081/aiua.2016.3.208.
10
Kidney stones: Composition, frequency and relation to metabolic diagnosis.肾结石:成分、发病率及其与代谢诊断的关系
Medicina (B Aires). 2016;76(6):343-348.

引用本文的文献

1
Nutritional considerations for designing ketogenic dietary interventions for people with Autosomal Dominant Polycystic Kidney Disease.为常染色体显性多囊肾病患者设计生酮饮食干预措施时的营养考量
J Nephrol. 2025 Aug 10. doi: 10.1007/s40620-025-02378-3.
2
The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease.无症状肾结石对常染色体显性遗传性多囊肾病疾病进展的影响。
BMC Nephrol. 2025 Feb 24;26(1):94. doi: 10.1186/s12882-025-03979-7.
3
Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease.
饮食干预治疗常染色体显性遗传性多囊肾病的潜在附加益处。
Nutrients. 2024 Aug 6;16(16):2582. doi: 10.3390/nu16162582.
4
Acute Kidney Injury Due to Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Treated With Tolvaptan: A Case Report.托伐普坦治疗常染色体显性多囊肾病患者肾结石所致急性肾损伤:一例报告
Cureus. 2024 Jun 18;16(6):e62597. doi: 10.7759/cureus.62597. eCollection 2024 Jun.
5
How Does ADPKD Severity Differ Between Family Members?常染色体显性多囊肾病在家庭成员之间的严重程度如何不同?
Kidney Int Rep. 2024 Feb 5;9(5):1198-1209. doi: 10.1016/j.ekir.2024.01.053. eCollection 2024 May.
6
Assessment of metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease: a cross-sectional study.常染色体显性多囊肾病患者肾结石代谢风险因素评估:一项横断面研究
Clin Exp Nephrol. 2023 Nov;27(11):912-918. doi: 10.1007/s10157-023-02378-2. Epub 2023 Jul 26.
7
The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease.尿过饱和度在常染色体显性多囊肾病进展中的作用。
J Nephrol. 2023 May;36(4):1011-1018. doi: 10.1007/s40620-022-01540-5. Epub 2022 Dec 17.
8
Increased Body Fat and Organic Acid Anions Production Are Associated with Larger Kidney Size in ADPKD.在 ADPKD 中,体脂肪增加和有机阴离子的产生与更大的肾脏大小有关。
Medicina (Kaunas). 2022 Jan 19;58(2):152. doi: 10.3390/medicina58020152.
9
Stone Prevalence in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.常染色体显性多囊肾病中的结石患病率:一项系统评价和荟萃分析。
Can J Kidney Health Dis. 2020 Jul 4;7:2054358120934628. doi: 10.1177/2054358120934628. eCollection 2020.
10
A comprehensive PGT-M strategy for ADPKD patients with de novo PKD1 mutations using affected embryo or gametes as proband.采用新发 PKD1 突变的 ADPKD 患者的受累胚胎或配子作为先证者的综合 PGT-M 策略。
J Assist Reprod Genet. 2021 Sep;38(9):2425-2434. doi: 10.1007/s10815-021-02188-z. Epub 2021 May 3.